Showing results (401-410 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|May 3, 2018
Crizotinib-induced simultaneous multiple cardiac toxicitiesTakuya Oyakawa, Nao Muraoka, Kei Iida, et al.
Investigational New Drugs|May 4, 2018
Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonistsA Molinos-Quintana, P Trujillo-Hacha, J I Piruat, et al.
Investigational New Drugs|August 1, 2018
Induction of endoplasmic reticulum stress by aminosteroid derivative RM-581 leads to tumor regression in PANC-1 xenograft modelMartin Perreault, René Maltais, Jenny Roy, et al.
Investigational New Drugs|June 9, 1999
Compatibility and stability of bryostatin 1 in infusion devicesA P Cheung, Y F Hallock, B R Vishnuvajjala, et al.
Investigational New Drugs|June 9, 1999
Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancerK Rajagopalan, D Peereboom, G T Budd, et al.
Investigational New Drugs|June 9, 1999
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinomaS Mani, T Schiano, J C Garcia, et al.
Investigational New Drugs|November 11, 1991
Amelioration of thrombocytopenia with concomitant ornithine in sarcoma-bearing rats receiving high dose difluoromethylornithineV B Grossie, D M Ota, J A Ajani, et al.
Investigational New Drugs|January 30, 2008
Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by a new series of substituted-1,3,4-oxadiazole derivativesAkhilesh Kumar, Saritha S D'Souza, S L Gaonkar, et al.
Investigational New Drugs|January 30, 2008
Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracilMichael J Kelner, Trevor C McMorris, Rafael J Rojas, et al.
Investigational New Drugs|January 25, 2008
Anticancer activity of a peptide combination in gastrointestinal cancers targeting multiple neuropeptide receptorsManu Jaggi, Sudhanand Prasad, Anu T Singh, et al.
Pageof 372